In patients with leukemia, complete remission after treatment is currently defined by the absence of cancer cells in a bone marrow biopsy viewed under the microscope. However, it’s well-established that if no further treatment is given, some patients will relapse due to undetectable cancer cells remaining in the body. This small number of remaining cells is known as minimal residual disease (MRD).
Ghayas Issa, M.D., assistant...
Triple-negative breast cancer (TNBC) is an aggressive disease that makes up roughly 15% to 20% of breast cancer diagnoses. Standard chemotherapy...